Spheroid AI

🚨 We’re excited to share some news at Spheroid AI! ⚠️ This is not a medical recommendation. We are in testing phase using a limited data sample. After months of dedicated work at the intersection of AI, oncology, and patient care, we’re proud to introduce Julia—our new AI-driven medical assistant, designed to help clinicians predict ovarian cancer and recommend individualized treatment options. What does this mean for patients and oncologists? Early detection: Julia analyzes complex clinical data to identify patterns that may indicate ovarian cancer or potential recurrence sooner, improving the likelihood of successful intervention. Tailored treatment insights: By building on our foundation cancer metabolism model—and enhancing it with patient-specific information—Julia empowers medical professionals to select more individualized, evidence-based treatment plans. Enhanced decision-making support: Julia delivers valuable, data-driven clinical insights that allow physicians to focus on what truly matters—providing compassionate, high-quality patient care. We believe that integrating AI and healthcare can transform patient outcomes and accelerate meaningful progress in the fight against cancer. And this is only the beginning. Spheroid AI is continuously supported by V1 Studio | District 3 Centre D'Innovation | Mila - Institut québécois d'intelligence artificielle in collaboration with Polytechnique Montréal ❤️ Join us as we continue pushing the boundaries of our heathcare system here in ‘Carebec’ ⚜️

Des nouvelles passionnantes du Centre universitaire de santé McGill | McGill University Health Centre (CUSM)! Les patients du CUSM sont parmi les premiers au monde à participer à des essais de traitement individualisé par ARNm pour le cancer du poumon. Cette recherche vise à utiliser la technologie de l'ARNm personnalisé pour créer des thérapies ciblées qui pourraient révolutionner le traitement de l'un des cancers les plus difficiles à traiter. 🔗 En savoir plus sur cette recherche : 📰 Article dans La Presse: https://lnkd.in/eEuqZ8ir 📰 Nouvelle du CUSM: https://lnkd.in/eEHcsnhG #Cancerdupoumon #ARNm #Médecinepersonnalisée ### Exciting news from the Centre universitaire de santé McGill | McGill University Health Centre (MUHC)! Patients at MUHC are among the first in the world to enroll in cutting-edge mRNA individualized treatment trials for lung cancer. This research aims to use personalized mRNA technology to create targeted therapies that could revolutionize the treatment of one of the most challenging cancers. 🔗 Learn more about this research: https://lnkd.in/eePK3xF3 #LungCancer #mRNA #CancerResearch #PersonalizedMedicine

NOW AVAILABLE: The 2024 Canadian Cancer Statistics release is here. Cancer has a substantial impact on the lives of people living in Canada and Canadian health care systems. Projected estimates of cancer in Canada in 2024 is a study published in the Canadian Medical Association Journal. This study provides new estimates of the number and rate of new cancer cases and deaths for 23 cancer types by: ➡️ province and territory ➡️ sex Keep swiping to read some of the key findings from the study. Visit this link to read the full report today: https://lnkd.in/g9riGvyZ #CancerStats #CancerInCanada